|
Real-time Estimate
Cboe Europe
10:15:46 2026-11-03 am EST
|
5-day change | 1st Jan Change | ||
| 15.71 SEK | -2.66% |
|
-12.44% | -30.27% |
| Market Cap | 904M 92.36M 82.46M 75.67M 68.83M 129M 8.74B 132M 364M 4.62B 347M 339M 14.58B | P/E 2026 * |
-9.61x | P/E 2027 * | -16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 929M 94.9M 84.72M 77.75M 70.72M 133M 8.98B 135M 374M 4.74B 356M 349M 14.98B | EV / Sales 2026 * |
21x | EV / Sales 2027 * | 45.3x |
| Free-Float |
74.7% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| SYNACT | Delayed | |
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| 8F8 | Delayed | |
|
Börse Stuttgart
| 8F8 | Delayed | |
|
CBOE
| Real-time | ||
|
Tradegate
| 8F8 | Real-time | |
|
Boerse Muenchen
| 8F8 | Real-time |
Last Transcript: SynAct Pharma AB
| 1 day | -2.60% | ||
| 1 week | -13.22% | ||
| Current month | -3.70% | ||
| 1 month | -8.76% | ||
| 3 months | -13.51% | ||
| 6 months | -8.12% | ||
| Current year | -30.88% |
| 1 week | 15.18 |  | 18.18 |
| 1 month | 15.18 | | 19.8 |
| Current year | 7.05 | | 24.4 |
| 1 year | 7.05 | | 24.5 |
| 3 years | 4.98 | | 25.3 |
| 5 years | 4.98 | | 146 |
| 10 years | 4.8 | | 146 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
CEO | Chief Executive Officer | 64 | 2013-12-31 |
Ann Kristin Led
DFI | Director of Finance/CFO | - | 2026-02-28 |
Kirsten Harting
CTO | Chief Tech/Sci/R&D Officer | - | 2024-02-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
BRD | Director/Board Member | 64 | 2024-03-19 |
Anders Kronborg
CHM | Chairman | 62 | 2024-03-19 |
Sten Scheibye
BRD | Director/Board Member | 75 | 2024-03-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/2/26 | Sell | Founder | -150,000 | 0.2813% | ||
| 9/2/26 | Sell | Chief Technology Officer | -350,000 | 0.6563% | ||
| 3/10/26 | Buy | Chairman | 2,750 | 0.0052% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.60% | -13.22% | -33.25% | +132.79% | 92.36M | |
| -0.46% | +10.31% | +63.52% | +143.15% | 1,257B | |
| -0.97% | +1.60% | +43.25% | +80.09% | 651B | |
| -2.05% | +0.73% | +32.47% | +101.62% | 510B | |
| -0.28% | -0.85% | +52.45% | +66.74% | 388B | |
| -0.78% | +5.51% | +72.55% | +44.25% | 366B | |
| +0.46% | +2.48% | +32.64% | +58.36% | 303B | |
| 0.00% | +7.97% | +11.97% | +34.80% | 288B | |
| -0.12% | +4.68% | +55.97% | +74.59% | 252B | |
| -0.21% | +7.34% | +42.19% | +109.69% | 211B | |
| Average | -0.68% | +3.17% | +37.38% | +84.61% | 422.68B | |
| Weighted average by Cap. | -0.45% | +5.30% | +49.17% | +93.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 44.25M 4.52M 4.04M 3.7M 3.37M 6.32M 428M 6.44M 17.84M 226M 16.97M 16.61M 714M | 21.6M 2.21M 1.97M 1.81M 1.65M 3.08M 209M 3.15M 8.71M 110M 8.28M 8.11M 348M |
| Net income | -47.08M -4.81M -4.3M -3.94M -3.59M -6.72M -456M -6.86M -18.98M -240M -18.06M -17.67M -759M | -31.92M -3.26M -2.91M -2.67M -2.43M -4.56M -309M -4.65M -12.87M -163M -12.24M -11.98M -515M |
| Net Debt | 24.81M 2.54M 2.26M 2.08M 1.89M 3.54M 240M 3.61M 10M 127M 9.52M 9.31M 400M | 74.22M 7.58M 6.77M 6.21M 5.65M 10.6M 718M 10.81M 29.92M 379M 28.47M 27.86M 1.2B |
Employees
8
Sector
Pharmaceuticals
Calendar
Nov. 02
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-03 | SEK 15.76 | -2.35% | 200,161 |
| 26-11-02 | SEK 16.14 | -0.49% | 246,055 |
| 26-10-30 | SEK 16.22 | -3.22% | 153,318 |
| 26-10-29 | SEK 16.76 | -4.12% | 84,149 |
| 26-10-28 | SEK 17.48 | -2.89% | 96,905 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SYNACT Stock
Select your edition
All financial news and data tailored to specific country editions
